Desloratadine NDC 69339-194

NDC codes

FDA NDC Directory

Product NDC (as listed)69339-194Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69339-0194Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69339-194-01	69339019401	100 TABLET, FILM COATED in 1 BOTTLE (69339-194-01)Marketed from Apr 1, 2026
69339-194-05	69339019405	500 TABLET, FILM COATED in 1 BOTTLE (69339-194-05)Marketed from Apr 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Desloratadine
Generic name (nonproprietary): desloratadine
Active ingredients: Desloratadine — 5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Natco Pharma USA LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078351
Marketing start: Apr 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Histamine H1 Receptor Antagonists (Mechanism)
Identifiers: Product ID 69339-194_e4db30a5-48e5-4fe3-8793-30b6866f87c1SPL ID e4db30a5-48e5-4fe3-8793-30b6866f87c1SPL set ID e4db30a5-48e5-4fe3-8793-30b6866f87c1RxCUI 349420UNII FVF865388RUPC 0369339194010, 0369339194058
Pharmacologic class: Histamine-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469339019401 followed by a unit qualifier and the quantity

Package 69339-0194-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 23, 2026.

Indications (excerpt from the label)

Desloratadine tablets are a histamine-1 (H1) receptor antagonist indicated for: Seasonal Allergic Rhinitis: relief of nasal and non-nasal symptoms in patients 12 years of age and older. ( 1.1 ) Perennial Allergic Rhinitis: relief of nasal and non-nasal symptoms in patients 12 years of age and older. ( 1.2 ) Chronic Idiopathic Urticaria: symptomatic relief of pruritus, reduction in the number of hives, and size of hives in patients 12 years of age and older. ( 1.3 ) 1.1 Seasonal Allergic Rhinitis Desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. 1.2 Perennial Allergic Rhinitis Desloratadi…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)